Fortress Biotech Inc. (FBIO) Rating Reiterated by FBR & Co
Other research analysts have also issued research reports about the stock. Roth Capital initiated coverage on shares of Fortress Biotech in a research report on Monday, October 3rd.
from Biotech News
0 Comments